Add group to favorites
Back to post list
Send new message to group Search:
Post Subject:
World Pharma News Digest - 18.02.2008
World Pharma News Digest - 18.02.2008
EUSA Pharma Out-Licenses Preclinical-Stage Human Antibody to
GlaxoSmithKline
EUSA Pharma Inc ('EUSA'), a transatlantic specialty pharmaceutical
company focused on oncology, pain control and critical care, today
announced that it has out-licensed the exclusive world-wide rights to
its preclinical-stage human anti-interleukin-6 antibody to
GlaxoSmithKline (GSK) for a consideration of up to US$44 million,
comprising an upfront fee and development milestones, plus royalties
on future sales.
Read more...
* w w w .worldpharmanews . com /content/view/295/1/
FDA grants fast track designation for Boehringer Ingelheim's BIBW
2992
Boehringer Ingelheim's investigational cancer treatment BIBW 2992 has
recently received a Fast Track Designation status by the FDA. Under
this designation, Boehringer Ingelheim will conduct a pivotal trial
programme studying BIBW 2992 in a non-small cell lung cancer (NSCLC)
patient group where prior treatment with reversible EGFR inhibitors
has failed.
Read more...
* w w w .worldpharmanews . com /content/view/294/1/
Abbott Receives FDA Approval for SIMCOR(R) (Niaspan(R) /
simvastatin)
Abbott received U.S. Food and Drug Administration (FDA) approval for
SIMCOR(R), the first fixed-dose combination of two widely prescribed
cholesterol therapies, Niaspan(R) (Abbott's proprietary niacin
extended-release) and simvastatin. SIMCOR is approved for use along
with diet to lower levels of elevated total cholesterol, LDL "bad"
cholesterol and triglycerides, and to raise HDL "good" cholesterol in
patients with complex lipid disease when treatment with simvastatin or
Niaspan monotherapies are not considered adequate.
Read more...
* w w w .worldpharmanews . com /content/view/293/1/
Risk of peripheral neuropathy with Sebivo (telbivudine)
The European Medicines Agency's (EMEA) Committee for Medicinal
Products for Human Use (CHMP) has recommended that new warnings be
included in the product information for Sebivo (telbivudine), from
Novartis Europharm Ltd. This warning is intended to inform doctors
about the risk of peripheral neuropathy in patients with chronic
hepatitis B who are being treated with Sebivo.
Read more...
* w w w .worldpharmanews . com /content/view/292/1/
Big Pharma Chooses Philadelphia Summit to discuss Business
Intelligence
An unprecedented Pharma speaker line-up will headline this 2008
flagship event. Attracting its usual mix of senior-level pharma and
biotech delegates, the event will act as a platform for the most
innovative speakers in pharma and a forum for debate to discuss how to
effectively communicate intelligence to make commercial decisions
faster, smarter and better.
Read more...
* w w w .worldpharmanews . com /content/view/291/1/
Pharmion and MethylGene Announce U.S. Orphan Drug Designation
Pharmion Corporation (Nasdaq: PHRM) and MethylGene Inc. (TSX: MYG)
today announced that the U.S. Food and Drug Administration (FDA) has
designated the Companies' histone deacetylase (HDAC) inhibitor,
MGCD0103, as an Orphan Drug for the treatment of acute myelogenous
leukemia (AML) in the United States.
Read more...
* w w w .worldpharmanews . com /content/view/290/1/
World Pharma News . net / Published News
PharmaGossip: Bayer - Trasylol: one thousand lives a month
* w w w .worldpharmanews . net /Product/PharmaGossip Bayer - Trasylol one thousand lives a month/
FDA grants fast track designation for Boehringer Ingelheim's BIBW 2992
* w w w .worldpharmanews . net /ClinicalTrials/FDA grants fast track designation for Boehringer Ingelheims BIBW 2992/
Courageous Sanity Triumphs Over Political Inanity (DrugWonks)
* w w w .worldpharmanews . net /Blogs/Courageous Sanity Triumphs Over Political Inanity DrugWonks/
Pharmalot Hassan Comes Clean About Vytorin. Or Did He?
* w w w .worldpharmanews . net /Blogs/Pharmalot - Hassan Comes Clean About Vytorin- Or Did He/
Scientific Misconduct Blog: What is the half-life of a pharmaceutical
scientific scandal?
* w w w .worldpharmanews . net /Blogs/Scientific Misconduct Blog What is the half-life of a pharmaceutical scientific scandal/
Abbott Receives FDA Approval for SIMCOR(R) (Niaspan(R) / simvastatin)
* w w w .worldpharmanews . net /Product/Abbott Receives FDA Approval for SIMCORR NiaspanR simvastatin/
Risk of peripheral neuropathy with Sebivo (telbivudine)
* w w w .worldpharmanews . net /Product/Risk of peripheral neuropathy with Sebivo telbivudine/
Pharmalot Bayer Delay Over Trasylol Took 22,000 Lives
* w w w .worldpharmanews . net /Blogs/Pharmalot - Bayer Delay Over Trasylol Took 22000 Lives/
GlaxoSmithKline buoyed by Buffett stake - Times Online
* w w w .worldpharmanews . net /Financial/GlaxoSmithKline buoyed by Buffett stake - Times Online/
Big Pharma Chooses Philadelphia Summit to discuss Business
Intelligence
* w w w .worldpharmanews . net /Conferences Events/Big Pharma Chooses Philadelphia Summit to discuss Business Intelligence/
EUSA Pharma Out-Licenses Preclinical-Stage Human Antibody to
GlaxoSmithKline
EUSA Pharma Inc ('EUSA'), a transatlantic specialty pharmaceutical
company focused on oncology, pain control and critical care, today
announced that it has out-licensed the exclusive world-wide rights to
its preclinical-stage human anti-interleukin-6 antibody to
GlaxoSmithKline (GSK) for a consideration of up to US$44 million,
comprising an upfront fee and development milestones, plus royalties
on future sales.
Read more...
* w w w .worldpharmanews . com /content/view/295/1/
FDA grants fast track designation for Boehringer Ingelheim's BIBW
2992
Boehringer Ingelheim's investigational cancer treatment BIBW 2992 has
recently received a Fast Track Designation status by the FDA. Under
this designation, Boehringer Ingelheim will conduct a pivotal trial
programme studying BIBW 2992 in a non-small cell lung cancer (NSCLC)
patient group where prior treatment with reversible EGFR inhibitors
has failed.
Read more...
* w w w .worldpharmanews . com /content/view/294/1/
Abbott Receives FDA Approval for SIMCOR(R) (Niaspan(R) /
simvastatin)
Abbott received U.S. Food and Drug Administration (FDA) approval for
SIMCOR(R), the first fixed-dose combination of two widely prescribed
cholesterol therapies, Niaspan(R) (Abbott's proprietary niacin
extended-release) and simvastatin. SIMCOR is approved for use along
with diet to lower levels of elevated total cholesterol, LDL "bad"
cholesterol and triglycerides, and to raise HDL "good" cholesterol in
patients with complex lipid disease when treatment with simvastatin or
Niaspan monotherapies are not considered adequate.
Read more...
* w w w .worldpharmanews . com /content/view/293/1/
Risk of peripheral neuropathy with Sebivo (telbivudine)
The European Medicines Agency's (EMEA) Committee for Medicinal
Products for Human Use (CHMP) has recommended that new warnings be
included in the product information for Sebivo (telbivudine), from
Novartis Europharm Ltd. This warning is intended to inform doctors
about the risk of peripheral neuropathy in patients with chronic
hepatitis B who are being treated with Sebivo.
Read more...
* w w w .worldpharmanews . com /content/view/292/1/
Big Pharma Chooses Philadelphia Summit to discuss Business
Intelligence
An unprecedented Pharma speaker line-up will headline this 2008
flagship event. Attracting its usual mix of senior-level pharma and
biotech delegates, the event will act as a platform for the most
innovative speakers in pharma and a forum for debate to discuss how to
effectively communicate intelligence to make commercial decisions
faster, smarter and better.
Read more...
* w w w .worldpharmanews . com /content/view/291/1/
Pharmion and MethylGene Announce U.S. Orphan Drug Designation
Pharmion Corporation (Nasdaq: PHRM) and MethylGene Inc. (TSX: MYG)
today announced that the U.S. Food and Drug Administration (FDA) has
designated the Companies' histone deacetylase (HDAC) inhibitor,
MGCD0103, as an Orphan Drug for the treatment of acute myelogenous
leukemia (AML) in the United States.
Read more...
* w w w .worldpharmanews . com /content/view/290/1/
World Pharma News . net / Published News
PharmaGossip: Bayer - Trasylol: one thousand lives a month
* w w w .worldpharmanews . net /Product/PharmaGossip Bayer - Trasylol one thousand lives a month/
FDA grants fast track designation for Boehringer Ingelheim's BIBW 2992
* w w w .worldpharmanews . net /ClinicalTrials/FDA grants fast track designation for Boehringer Ingelheims BIBW 2992/
Courageous Sanity Triumphs Over Political Inanity (DrugWonks)
* w w w .worldpharmanews . net /Blogs/Courageous Sanity Triumphs Over Political Inanity DrugWonks/
Pharmalot Hassan Comes Clean About Vytorin. Or Did He?
* w w w .worldpharmanews . net /Blogs/Pharmalot - Hassan Comes Clean About Vytorin- Or Did He/
Scientific Misconduct Blog: What is the half-life of a pharmaceutical
scientific scandal?
* w w w .worldpharmanews . net /Blogs/Scientific Misconduct Blog What is the half-life of a pharmaceutical scientific scandal/
Abbott Receives FDA Approval for SIMCOR(R) (Niaspan(R) / simvastatin)
* w w w .worldpharmanews . net /Product/Abbott Receives FDA Approval for SIMCORR NiaspanR simvastatin/
Risk of peripheral neuropathy with Sebivo (telbivudine)
* w w w .worldpharmanews . net /Product/Risk of peripheral neuropathy with Sebivo telbivudine/
Pharmalot Bayer Delay Over Trasylol Took 22,000 Lives
* w w w .worldpharmanews . net /Blogs/Pharmalot - Bayer Delay Over Trasylol Took 22000 Lives/
GlaxoSmithKline buoyed by Buffett stake - Times Online
* w w w .worldpharmanews . net /Financial/GlaxoSmithKline buoyed by Buffett stake - Times Online/
Big Pharma Chooses Philadelphia Summit to discuss Business
Intelligence
* w w w .worldpharmanews . net /Conferences Events/Big Pharma Chooses Philadelphia Summit to discuss Business Intelligence/
Next: World Pharma News Digest - 20.02.2008
Previous: Lipstick with lead? check * w w w .cosmeticdatabase . com
